#5397 FRAILTY ASSESSMENT TOOLS, SURVIVAL TIME AND TIME TO INITIATE DIALYSIS IN OLDER PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE

نویسندگان

چکیده

Abstract Background and Aims Chronic Kidney Disease (CKD) patients with frailty have been shown to a shorter survival time compared non-frail individuals. Additionally, has linked earlier initiation of dialysis among CKD patients. Despite the availability over 50 assessment tools in literature, few applied studies older adults CKD. There is need for comprehensive analysis different identify most accurate that could predict start The present study compares four commonly used from categories (self-reporting tools, clinical judgment complex instruments) regarding their association dialysis. Method Two hundred forty biochemical evidence Stages 4–5 were included this prospective cohort study. inclusion criteria 65 years old or more two consecutive measurements estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 separated by than three months, while exclusion dependence, history kidney transplantation, recent acute injury, initial visit provider, amputation, cerebrovascular accident. Prisma-7 FRAIL Scale, Clinical Frailty Scale (CFS), Phenotype (FP). Patients followed-up 36 months death events initiation. Results population (240 patients) comprised 46% male mean age 73.8 ± 6.6 years. Approximately 25% considered frail using scale, 69% Prisma-7, almost 40% CFS FP. Except “frail” patients, as determined FRAIL, CFS, FP scores (Fig. 1), had significantly times, 24.9 (Log-rank p <0.001), 27.3 = 0.041), 26.6 0.004) respectively. No significant differences observed when comparing any (Table 1). Conclusion findings suggest derived are better predictors elderly CKD, further research required determine appropriate tool population.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease

Introduction Dipyridamole decreases proteinuria and improves renal function progression in patients with glomerular disease through its inhibition of platelet activation and enhanced nitric oxide expression. Few studies have evaluated the effects of dipyridamole on renal outcome or survival in CKD stage 5 patients who have not yet received dialysis (CKD 5 ND). Materials and Methods A prospect...

متن کامل

Comparative Survival among Older Adults with Advanced Kidney Disease Managed Conservatively Versus with Dialysis.

BACKGROUND AND OBJECTIVES Outcomes of older patients with ESRD undergoing RRT or conservative management (CM) are uncertain. Adequate survival data, specifically of older patients, are needed for proper counseling. We compared survival of older renal patients choosing either CM or RRT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS A retrospective survival analysis was performed of a single-ce...

متن کامل

[Prevalence of frailty in patients in chronic kidney disease on conservative treatment and on dialysis].

INTRODUCTION Frailty is a physiological vulnerability status of the patient which is associated with the increased number of hospitalization and death. OBJECTIVES To evaluate the prevalence of frailty and its associated factors in patients with chronic kidney disease (CKD) on conservative treatment (CT), hemodialysis (HD) and peritoneal dialysis (PD). METHODS Frailty was assessed in 146 pat...

متن کامل

Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease

BACKGROUND The benefit of alpha-Ketoanalogues (KA) supplementation for chronic kidney disease (CKD) patients that followed low-protein diet (LPD) remains undetermined. METHODS We extracted longitudinal data for all CKD patients in the Taiwan National Health Insurance from January 1, 2000 through December 31, 2010. A total of 1483 patients with anemic advanced CKD treated with LPD, who started...

متن کامل

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

Nonvitamin K-dependent oral anticoagulant agents (NOACs) are currently recommended for patients with atrial fibrillation at risk for stroke. As a group, NOACs significantly reduce stroke, intracranial hemorrhage, and mortality, with lower to similar major bleeding rates compared with warfarin. All NOACs are dependent on the kidney for elimination, such that patients with creatinine clearance <2...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nephrology Dialysis Transplantation

سال: 2023

ISSN: ['1460-2385', '0931-0509']

DOI: https://doi.org/10.1093/ndt/gfad063c_5397